See Ching Chan, Sheung Tat Fan, Chi Leung Liu, Chung Mau Lo, Banny K. Lam, Evelyn W. Lee – 29 March 2007 – Donor workup for adult‐to‐adult live donor liver transplantation is done to ensure that the donor remains physically and psychologically healthy after saving or improving the life of the recipient. Even though two‐thirds of the liver transplants in our center were from live donors, this life‐saving procedure remains a mere treatment option, given the magnitude of the donor operation with the associated donor risks.

29 March 2007

29 March 2007

Xavier Stéphenne, Olivier Vosters, Mustapha Najimi, Claire Beuneu, Dung Khuu Ngoc, Walter Wijns, Michel Goldman, Etienne M. Sokal – 29 March 2007 – Liver cell transplantation (LCT) aims to correct inborn liver function defects by infusing metabolically active cells into the diseased liver. Further improvement in LCT might depend on the prevention of early loss of transplanted cells.

Evangelos Cholongitas, Marco Senzolo, Alberto Quaglia, David Patch, Amar P. Dhillon, Andrew K. Burroughs – 29 March 2007

Gi‐Young Ko, Kyu‐Bo Sung, Hyun‐Ki Yoon, SungGyu Lee – 29 March 2007 – Surgical treatments have usually been preferred for early posttransplantation portal inflow abnormalities. However, these treatments are limited due to their technical difficulty and multiple complicating factors. The present study reports the efficacy and safety of percutaneous transhepatic primary stent placement to treat early posttransplantation (≤1 month) portal vein (PV) stenosis. A total of 9 patients who had undergone living donor liver transplantation underwent percutaneous stent placement to treat PV stenosis.

Robert A. Fisher – 29 March 2007

29 March 2007

Makoto Osawa, Yutaka Ito, Toyohiro Hirai, Rie Isozumi, Shunji Takakura, Yasuhiro Fujimoto, Yoshitsugu Iinuma, Satoshi Ichiyama, Koichi Tanaka, Michiaki Mishima – 29 March 2007 – Invasive aspergillosis (IA) is a severe complication of liver transplantation. Risk factors for IA after deceased donor liver transplantation (DDLT) have been presented in several reports, but are not well established for living donor liver transplant recipients. Here, a retrospective case‐control study was performed.

Hiroto Egawa, Katsuyuki Ohmori, Hironori Haga, Hiroaki Tsuji, Kimiko Yurugi, Aya Miyagawa‐Hayashino, Fumitaka Oike, Akinari Fukuda, Jun Yoshizawa, Yasutsugu Takada, Koichi Tanaka, Taira Maekawa, Kazue Ozawa, Shinji Uemoto – 29 March 2007 – Although the effectiveness of rituximab has been reported in ABO blood group (ABO)‐incompatible (ABO‐I) organ transplantation, the protocol is not yet established.